Enantioselective synthesis and absolute configuration of (-)-1-(benzofuran-2-yl)-2-propylaminopentane, ((-)-BPAP), a highly potent and selective catecholaminergic activity enhancer.

[1]  D. M. Weinstein,et al.  Design and synthesis of enantiomers of 3,5-dinitro-o-tyrosine: alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropanoic acid (AMPA) receptor antagonists. , 1998, Journal of medicinal chemistry.

[2]  J. Knoll,et al.  (-)Deprenyl (selegiline), a catecholaminergic activity enhancer (CAE) substance acting in the brain. , 1998, Pharmacology & toxicology.

[3]  J. Knoll Sexual performance and longevity , 1997, Experimental Gerontology.

[4]  T. Eisner,et al.  Absolute configuration of insect-produced epilachnene , 1997 .

[5]  J. Knoll,et al.  Enhanced catecholaminergic and serotoninergic activity in rat brain from weaning to sexual maturity: rationale for prophylactic (-)deprenyl (selegiline) medication. , 1995, Life sciences.

[6]  P. Edwards,et al.  Peptidyl alpha-ketoheterocyclic inhibitors of human neutrophil elastase. 2. Effect of varying the heterocyclic ring on in vitro potency. , 1995, Journal of medicinal chemistry.

[7]  J. Knoll Rationale for (-)deprenyl (selegiline) medication in Parkinson's disease and in prevention of age-related nigral changes. , 1995, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[8]  J. Knoll Memories of my 45 years in research. , 1994, Pharmacology & toxicology.

[9]  W. Tatton,et al.  Rescue of dying neurons: A new action for deprenyl in MPTP parkinsonism , 1991, Journal of neuroscience research.

[10]  J. Langston,et al.  The effect of deprenyl (selegiline) on the natural history of Parkinson's disease. , 1989, Science.

[11]  Anthony E. Lang,et al.  Effect of deprenyl on the progression of disability in early Parkinson's disease. , 1989, The New England journal of medicine.

[12]  J. Knoll The striatal dopamine dependency of life span in male rats. Longevity study with (−)deprenyl , 1988, Mechanisms of Ageing and Development.

[13]  A. Treasurywala,et al.  Enantiomeric effects of homologues of disoxaril on the inhibitory activity against human rhinovirus-14. , 1988, Journal of medicinal chemistry.